As shown in figure 2A–C, the expression of cytotoxic molecules in tumor CD8+ T cells was significantly upregulated after genetical or pharmacologic inhibition of KDM4C, indicating that KDM4C inhibition promotes the activation of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.